• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

Introduction to N,N-Dimethyl-5-((4-methylpiperazin-1-yl)methyl)pyridin-2-amine (CAS No. 1245644-05-6)

N,N-Dimethyl-5-((4-methylpiperazin-1-yl)methyl)pyridin-2-amine, with the chemical identifier CAS No. 1245644-05-6, is a compound that has garnered significant attention in the field of pharmaceutical research due to its unique structural properties and potential biological activities. This compound belongs to the class of pyridine derivatives, which are well-known for their diverse applications in medicinal chemistry. The presence of multiple functional groups, including amines and piperazine moieties, makes this molecule a promising candidate for further exploration in drug discovery.

The< strong>N,N-Dimethyl-5-((4-methylpiperazin-1-yl)methyl)pyridin-2-amine molecule exhibits a complex structure that incorporates a pyridine core substituted with a dimethylamine group at the 2-position and a 4-methylpiperazine moiety at the 5-position. This specific arrangement of functional groups contributes to its potential interactions with various biological targets, making it an intriguing subject for synthetic chemists and pharmacologists.

In recent years, there has been a growing interest in developing novel therapeutic agents that target central nervous system (CNS) disorders. Pyridine derivatives have shown promise in this area due to their ability to modulate neurotransmitter systems. The< strong>4-methylpiperazine component of N,N-Dimethyl-5-((4-methylpiperazin-1-yl)methyl)pyridin-2-amine is particularly noteworthy, as it is a common pharmacophore in drugs used to treat conditions such as depression and schizophrenia.

Recent studies have highlighted the importance of< strong>piperazine derivatives in the development of CNS-active compounds. These studies suggest that the piperazine moiety can enhance binding affinity and selectivity for certain receptors, thereby improving therapeutic efficacy while minimizing side effects. The< strong>N,N-Dimethyl group in the compound further contributes to its pharmacological profile by influencing its solubility and metabolic stability.

The synthesis of N,N-Dimethyl-5-((4-methylpiperazin-1-yl)methyl)pyridin-2-amine involves multi-step organic reactions, typically starting from commercially available pyridine derivatives. The introduction of the< strong>4-methylpiperazine moiety requires careful consideration of reaction conditions to ensure high yield and purity. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to explore this compound further in preclinical studies.

In preclinical research, N,N-Dimethyl-5-((4-methylpiperazin-1-yl)methyl)pyridin-2-amine has been evaluated for its potential as an intermediate in the development of novel drugs. Initial findings suggest that it may exhibit properties relevant to the treatment of neurological disorders, although further investigation is necessary to fully understand its mechanism of action. The compound's ability to interact with multiple targets makes it a versatile tool for drug design and optimization.

The< strong>CAS No. 1245644 designation ensures that researchers can accurately identify and procure this compound for their studies. As more data becomes available on its biological activity and pharmacokinetic properties, it is expected that N,N-Dimethyl-N-(3-chloropropyl)-3-(dimethoxyphenyl)urea will continue to be a subject of interest in pharmaceutical research.

The development of new drugs is a complex process that involves extensive testing and validation. N,N-Dimethylaniline plays a crucial role in this process by serving as a building block for more complex molecules. Its unique structural features make it a valuable asset in the drug discovery pipeline, particularly for targeting CNS-related conditions.

In conclusion, N,N-Dimethylaniline is a compound with significant potential in pharmaceutical research. Its structural complexity and functional groups make it an attractive candidate for further exploration in drug development. As our understanding of its biological activities grows, so too does its importance in the search for new therapeutic agents.

• 104395-86-0(1-(5-Methyl-2-pyridinyl)piperazine)
• 1152523-44-8(N-5-(Aminomethyl)-2-pyridinyl-N-benzyl-N-ethylamine)
• 1322622-11-6(3-Pyridinemethanamine, 6-(dimethylamino)-N,N-dimethyl-)
• 1185307-85-0(1-(5-methyl-2-pyridyl)piperazine;hydrochloride)
• 1178566-47-6(5-(1-piperazinylmethyl)-2-Pyridinamine)
• 767628-83-1(1-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]methanamine)
• 1210961-10-6(1-[6-(4-methylpiperazin-1-yl)pyridin-3-yl]methanamine dihydrochloride)
• 63980-42-7(Piperazine,1-(phenylmethyl)-4-(2-pyridinyl)-)
• 1197333-44-0(5-[(4-methyl-1-piperazinyl)methyl]-2-Pyridinamine)
• 1180132-17-5([5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl]amine)